Skip to content

Clinical trials

Hepatitis B trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis B Country / region: Brazil Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20071
20091
20121
20171
20201
20211
20222
20231
20243
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting3
Not yet recruiting1
Terminated1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline5
National Institute of Allergy and Infectious Diseases (NIAID)3
Bristol-Myers Squibb2
HIV Prevention Trials Network1
Novartis Pharmaceuticals1
Pharmasset1
Universidade Federal de Goias1
University of North Carolina, Chapel Hill1
Vitalant Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis B16
Hepatitis B, Chronic5
HIV Infections4
Hepatitis, Chronic4
Hepatitis3
Acquired Immunodeficiency Syndrome2
Chagas Disease1
DNA Virus Infections1
Digestive System Diseases1
Hepatitis C1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.